Viewing Study NCT03944759


Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2025-12-24 @ 2:44 PM
Study NCT ID: NCT03944759
Status: COMPLETED
Last Update Posted: 2020-02-12
First Post: 2019-05-06
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy of Serratus Anterior Plane Block Mastectomy
Sponsor: doaa rashwan
Organization:

Study Overview

Official Title: Efficacy of Serratus Anterior Plane Block Using Bupivacaine/Magnesium Sulphate Versus Bupivacaine/Nalbuphine for Mastectomy: a Randomized Double Blinded Comparative Study
Status: COMPLETED
Status Verified Date: 2020-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Breast cancer is the main common cancer among females. . Inadequate control of pain may later develop into chronic pain syndrome (paraesthesias, phantom breast pain, and intercostobrachial neuralgia) in 25-40% of the patients .
Detailed Description: The aim of this study is to compare the efficacy of ultrasound-guided serratus anterior plane block with bupivacaine/ magnesium versus bupivacaine/ nalbuphine in breast cancer surgery.

Patients and methods nclusion criteria:

-ASA I and II female patients, age 25-60 undergoing breast cancer surgery

Exclusion criteria:

* Patient refusal
* Contraindications for regional blocks (eg. Infection at the injection site, coagulopathy)
* Allergy to the drugs used in the study
* Chronic pain therapy,
* BMI more than 30 kg/m2

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: